3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
16
Carcinoma, Renal Cell
14
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma, Hepatocellular
7
Neoplasms
6
Carcinoma, Medullary
6
Thyroid Neoplasms
5
Melanoma
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Neuroendocrine Tumors
4
Carcinoma, Transitional Cell
4
Brain Neoplasms
4
Thyroid Cancer, Papillary
3
Small Cell Lung Carcinoma
3
Sarcoma
3
Pancreatic Neoplasms
3
Lung Neoplasms
3
Kidney Neoplasms
3
Adenocarcinoma, Follicular
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Recurrence
2
Pheochromocytoma
2
Paraganglioma
2
Pain
2
Osteosarcoma
2
Multiple Myeloma
2
Interventions
Gemcitabine
4
Cisplatin
4
Carboplatin
3
pembrolizumab
2
erdafitinib
2
durvalumab
2
vinflunine
1
tremelimumab
1
enfortumab vedotin
1
avelumab
1
Sunitinib
1
Radiotherapy
1
Paclitaxel
1
Nivolumab
1
Midazolam
1
Metformin
1
Ipilimumab
1
Docetaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Urothelial Cancer
×
cabozantinib
×
Clear all
No trials found.